Düsseldorf, Germany — Bioer Technology proudly participated in the highly anticipated MEDICA 2024, held from November 11 to 14 at the Düsseldorf Exhibition Center in Germany. As the world’s largest and most prestigious medical device exhibition, MEDICA attracts thousands of exhibitors and tens of thousands of professional visitors from over 70 countries, making it a key event in the global healthcare and medical technology landscape.
At this year’s exhibition, Bioer Technology presented its latest innovations, including three star products that are revolutionizing the molecular diagnostics space:
- Droplet Chip Digital PCR Analysis System
-
/uploadfiles/2024/11/20241115094221008.pdf
- CentriDx™ Automated Nucleic Acid Detection Analyzer
-
/uploadfiles/2024/11/20241115094348120.pdf
- AutoGene 9600 Automatic PCR Analysis System
-
/uploadfiles/2024/11/20241115094410929.pdf
These cutting-edge solutions reflect Bioer Technology’s commitment to advancing medical diagnostics with high-performance, user-friendly instruments. The company’s participation in MEDICA 2024 marks an important milestone in engaging with the global medical community, discussing emerging trends in healthcare, and showcasing its ongoing dedication to innovation in the molecular diagnostics field.
Droplet Chip Digital PCR Analysis System, a six-multiplex digital PCR platform designed for the precise and ultrasensitive quantification of nucleic acids without the need for standard curves.It is primarily applied for gene copy number analysis, mutation detection, and viral load measurement, providing precise results even for low-frequency targets. dPCR is also used for gene expression analysis and absolute quantification without needing a standard curve. Its ability to detect small amounts of DNA or RNA makes it valuable in cancer research, infectious disease diagnostics, and food safety testing.
CentriDx™ Automated Nucleic Acid Detection Analyzer, designed and developed by Bioer Technology, leverages advanced microfluidic chip technology combined with unique centrifugal rotation (including acceleration, deceleration, and positioning) to drive precise liquid flow and mixing. CentriDx™ enables seamless nucleic acid extraction, amplification, and detection processes within the microfluidic chip, streamlining experiments for enhanced simplicity, speed, and accuracy. With its compact, user-friendly design, CentriDx™ requires no setup or calibration procedures - simply plug and play. Currently, there are reagent kits available for respiratory multiplex detection (upper and lower respiratory tracts), gastrointestinal, and sexually transmitted diseases (STDs).
The AutoGene 9600 Automatic PCR Analysis System is an advanced, fully integrated solution designed to streamline and automate the entire PCR workflow. This state-of-the-art system automates every step of the process, including decapping and recapping, nucleic acid extraction, PCR System setup, sealing film, qPCR and data analysis. The detection kits cover a wide range of fields, including respiratory tract, sexually transmitted diseases (STDs), blood infections, oncology, and gastrointestinal diseases.
With over 20 years of dedication to the life sciences industry, Bioer Technology continues to invest heavily in research and development. This sustained focus on innovation has solidified the company’s position as a leader in the molecular diagnostics field. Looking forward, Bioer Technology is committed to driving further advancements in life sciences, ensuring that their technologies remain at the forefront of laboratory solutions worldwide.
